Related references
Note: Only part of the references are listed.Complications of Phosphate and Vitamin D Treatment in X-Linked Hypophosphataemia
Pedro Arango Sancho
ADVANCES IN THERAPY (2020)
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Signe Sparre Beck-Nielsen et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel et al.
LANCET (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients
Sean DeLacey et al.
BONE (2019)
Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion
Patricia P. Centeno et al.
NATURE COMMUNICATIONS (2019)
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial
Michael P. Whyte et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia
M. Biosse Duplan et al.
JOURNAL OF DENTAL RESEARCH (2017)
Effect of Calcitriol on FGF23 Level in Healthy Adults and its Dependence on Phosphate Level
Effrosyni Georgiadou et al.
IN VIVO (2017)
1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression
Eva S. Liu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease
Jessica Connor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Therapeutic management of hypophosphatemic rickets from infancy to adulthood
Agnes Linglart et al.
ENDOCRINE CONNECTIONS (2014)
A Clinician's Guide to X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23
Clemens Bergwitz et al.
ANNUAL REVIEW OF MEDICINE (2010)
Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Growth in X-linked hypophosphatemic rickets
Gema Ariceta et al.
EUROPEAN JOURNAL OF PEDIATRICS (2007)
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
Diana M. Antoniucci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia
DH Su et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2006)
Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets
O Mäkitie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Radiographic scoring method for the assessment of the severity of nutritional rickets
TD Thacher et al.
JOURNAL OF TROPICAL PEDIATRICS (2000)
Share Paper
